Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway.


Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
08 2019
Historique:
received: 08 11 2018
revised: 28 01 2019
accepted: 30 01 2019
pubmed: 17 2 2019
medline: 2 6 2020
entrez: 17 2 2019
Statut: ppublish

Résumé

To study the effects of curcumin on human retinal pigment epithelial (RPE) cells exposed to high glucose (HG) insult, we performed in vitro studies on RPE cells cultured both in normal and HG conditions to assess the effects of curcumin on the cell viability, nuclear factor erythroid 2-related factor 2 (Nrf2) expression, HO-1 activity, and ERK1/2 expression. RPE cells exposed to HG insult were treated with curcumin. The cell viability, apoptosis, HO-1 activity, ERK, and Nrf2 expression were evaluated. The data indicated that treatment with curcumin caused a significant decrease in terms of apoptosis. Further, curcumin was able to induce HO-1 expression via Nrf2 activation and counteracts the damage elicited by HG. The present study demonstrated that curcumin provides protection against HG-induced damage in RPE cells through the activation of Nrf2/HO-1 signaling that involves the ERK pathway, suggesting that curcumin may have therapeutic value in the treatment of diabetic retinopathy.

Identifiants

pubmed: 30770549
doi: 10.1002/jcp.28347
doi:

Substances chimiques

NF-E2-Related Factor 2 0
NFE2L2 protein, human 0
Reactive Oxygen Species 0
Heme Oxygenase-1 EC 1.14.14.18
Curcumin IT942ZTH98
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17295-17304

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Claudio Bucolo (C)

Department of Biomedical and Biotechnological Sciences, Pharmacology Section, University of Catania, Catania, Italy.
Center for Research in Ocular Pharmacology - CERFO-, School of Medicine, University of Catania, Catania, Italy.

Filippo Drago (F)

Department of Biomedical and Biotechnological Sciences, Pharmacology Section, University of Catania, Catania, Italy.
Center for Research in Ocular Pharmacology - CERFO-, School of Medicine, University of Catania, Catania, Italy.

Rosa Maisto (R)

Facultad de Medicina y Odontologìa Universidad Católica de Valencia "San Vicente Mártir", Valencia, Spain.

Giovanni Luca Romano (GL)

Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami Miller School of Medicine, Miami, USA.

Velia D'Agata (V)

Department of Biomedical and Biotechnological Sciences, Human Anatomy and Histology Section, University of Catania, Catania, Italy.

Grazia Maugeri (G)

Department of Biomedical and Biotechnological Sciences, Human Anatomy and Histology Section, University of Catania, Catania, Italy.

Salvatore Giunta (S)

Department of Biomedical and Biotechnological Sciences, Human Anatomy and Histology Section, University of Catania, Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH